Abstract:OBJECTIVE:To apply the fluorescent quantitative PCR method on the detection of Trisomy 21 by D21S11 locus and make a foundation for rapid prenatal diagnosis of Trisomy 21.METHODS:About 409 controls (39 amniotic fluid samples and 370 peripheral blood samples) and 35 patients (4 amniotic fluid samples and 31 peripheral blood samples) with Trisomy 21 were tested using fluorescent quantitative PCR by amplification of DNA fragment on D21S11 STR locus. The results were compared with conventional cytogenetic analysis to confirm the utility of this method. And the allele frequency distributions of D21S11 STR locus were analyzed.RESULTS:The 95% reference interval of fluorescent intensity ratios of peak heights of PCR products amplified from two alleles on D21S11 locus ranged from 0.84 to 1.42 (1.13 +/- 0.29) in heterozygous controls. About 19 out of 35 patients showed a "diallelic" pattern and their height ratio of fluorescent peaks of PCR products amplified from two alleles in patients with "diallelic" patterns were all outside of the 95% reference range of controls. The PCR products of DNA from 12 patients presented the third allele. No sample with the "monoallelic" pattern was found. Four chimeras diagnosed by cytogenetic method could not be diagnosed by this method. There were 17 and 11 alleles found in controls and patients, respectively. About 343 out of 409 controls were heterozygous and the heterozygosity was 83.86%. We did not find any significant differences in the frequency distributions of alleles on D21S11 locus between controls and patients. But there were significant differences in the frequency distributions of alleles on D21S11 locus between controls and patients. But there were significant differences in the frequency distributions of alleles on D21S11 locus among different populations.CONCLUSIONS:The fluorescent quantitative polymerase chain reaction method was rapid, accurate, and only small amount of starting material was needed, it could be applied in rapid prenatal diagnosis of Trisomy 21. D21S11 was a good marker with high heterozygosity for the screening of Trisomy 21. And the frequency distributions of alleles on D21S11 locus were significantly related to ethnic background.

Molecular Cytogenetic Detection of Trisomy 21 in Interphase Nuclei and Metaphase Chromosomes.

[Rapid Detection of Chromosomes X and Y Using Dual-Color Primed in Situ Labeling Technique].

Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.

The use of the primed in situ labeling technique in the diagnosis of 21-trisomy syndrome

Rapid detection of 18-trisomy syndrome using primed in situ labeling technique

Noninvasive Prenatal Testing of Trisomies 21 and 18 by Massively Parallel Sequencing of Maternal Plasma DNA in Twin Pregnancies.

Conventional and molecular cytogenetic analyses of a derivative X chromosome in amniocentesis

Noninvasive Prenatal Screening of Fetal Aneuploidy without Massively Parallel Sequencing

Rapid Detection of Chromosome 18 Aneuploidies in Amniocytes by Using Primed in Situ Labeling (PRINS) Technique

Noninvasive prenatal diagnosis of trisomy 21 using analysis of short tandem repeats

Study on rapid genetic diagnosis of trisomy 21

Primary Study on Prenatal Molecular Diagnosis of Down Syndrome

[Application of Real-Time Fluorescence Quantitative Polymerase Chain Reaction Techniques for Prenatal Diagnosis of Down Syndrome].

Preparation of human chromosome 21 DNA painting probe and applied to diagnosis of Down′s syndrome.

Quantitative Real‐time PCR Technique for Rapid Prenatal Diagnosis of Down Syndrome

Practical Application of Fluorescent Quantitative PCR on Trisomy 21 in Chinese Han Population

Application of the 13/21 Α Satellite Probe Which Was Amplified by PCR for the Study of Prenatal Diagnosis

Novel Real-Time Pcr Assay for Rapid Prenatal Diagnosis of Down Syndrome: A Prospective Study of 563 Amniocytes

Rapid Detection of Chromosomal Aneuploidies by Multiplex Ligation-Dependent Probe Amplification

[Use of the Primed in Situ Labeling Technique for a Rapid Detection of Chromosomes X, 18].

Prenatal Diagnosis of Down Syndrome Using Cell-Free Fetal DNA in Amniotic Fluid by Quantitative Fluorescent Polymersase Chain Reaction.